The holy grail of oncology has always been to catch cancer when it is most treatable—at its earliest, most nascent stages. For years, this has been an incredible challenge, but we're now at a thrilling inflection point where artificial intelligence is meeting molecular biology to create solutions
Praxis Precision Medicines, a clinical-stage biopharmaceutical company dedicated to developing therapies for complex central nervous system disorders, has made a significant financial move by announcing the pricing of its underwritten public offering, which is expected to generate gross proceeds of
A landmark study examining mental health care delivery for millions of Medicare beneficiaries has revealed that telehealth, once a temporary measure, has firmly established itself as a dominant and permanent fixture in the healthcare landscape, fundamentally reshaping how patients access services
The intricate symphony of the human brain has long been played through a filter of heavy static, but a revolutionary AI conductor is finally allowing scientists to hear the music clearly for the first time. For decades, researchers have relied on functional magnetic resonance imaging (fMRI) to
Sevoflurane has long been a cornerstone of pediatric anesthesia, allowing millions of children to undergo necessary surgical procedures safely and without pain each year. Despite its widespread and effective use, a shadow of concern has emerged from preclinical research, where animal studies have
Intraventricular hemorrhage, a form of bleeding within the brain's delicate ventricles, represents one of the most significant threats to the long-term health and neurodevelopment of preterm infants. For decades, the standard of care has been largely reactive, identifying brain bleeds only after
